We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current DAITF market cap is 208.14M. The company's latest EPS is JPY 207.8573 and P/E is 0.06.
| Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 44.99B | 48.71B | 43.46B | 45.1B | 46.9B |
| Operating Income | 5.36B | 5.7B | 6.55B | 5.21B | 3.89B |
| Net Income | 3.94B | 4.25B | 4.67B | 3.6B | 3.3B |
| Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 54.25B | 57.74B | 64.94B | 70.55B | 77.71B |
| Total Liabilities | 17.38B | 15.82B | 17.27B | 19.58B | 25.44B |
| Total Equity | 36.87B | 41.92B | 47.67B | 50.97B | 52.27B |
| Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 4.31B | 5.18B | 4.37B | 4.16B | N/A |
| Investing | -2.68B | -6.32B | -4.4B | -5.57B | N/A |
| Financing | -350.46M | 1.42B | 989M | 618M | N/A |
| Market Cap | 208.14M |
| Price to Earnings Ratio | 0.06 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.08 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 15.85M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 13.13 |
| 52 Week Low | 13.13 |
| Spread (Intraday) | 8.06 (44.63%) |
| Company Name | Daito Pharmaceutical Company Ltd (PK) |
| Address |
326 yokamachi toyama, toyama 939-8567 |
| Website | https://www.daitonet.co.jp |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
